In 1974 there was an increasing awareness at the National Cancer Institute of the U.S.A. that important drugs might have been missed by the conventional murine tumor screening system then employed. Differences in biochemistry and cell biology of murine vs. human tumors were increasingly well understood. Among these were growth kinetic properties, membrane transport rates, preferential metabolic pathways, nucleotide pool regulatory mechanisms, and preferential mode of DNA repair.